| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/16/2004 | US20040253647 Evaluating modulators effectiveness as treatment for alzheimer's via quantifying amyloid precursor protein peptide cleavage products present after exposure agonist/antagonist |
| 12/16/2004 | US20040253610 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for use in identifying modulators for treatment of inflammatory, cardiovacullar, vision and cancer disorders |
| 12/16/2004 | US20040253608 Compounds with anti-KS and anti-HIV activity |
| 12/16/2004 | US20040253576 Using synergistic relationship between dopamine receptors to identify modulators which modify slow a-type potassium current activity (IAS) in cells; for use in treatment of alcohol/drug addiction |
| 12/16/2004 | US20040253460 Functionalized silicon compounds and methods for their synthesis and use |
| 12/16/2004 | US20040253332 Method for regulating the appearance of skin containing combination of skin care actives |
| 12/16/2004 | US20040253329 Ligand for peroxisome proliferator-activated receptor |
| 12/16/2004 | US20040253327 Prophylactically administering a drug mixture containing psyllium husk, I2-sitosterol, guggul tree extract, guar gum and chromium; reducing low density lipoproteins, blood sugar and increasing high density lipoproteins; dietary supplement |
| 12/16/2004 | US20040253326 Composition for increasing levels of hormones and a method for preparation of said composition |
| 12/16/2004 | US20040253323 An aqueous alkali metal salt solution contains cesium and rubidium salt of chloride, sulfate, carbonate, phosphate, lactate, citrate, and acetate; antitumor agents, antiproliferative agents; inhibiting secretion of tumor proteases, increase pH to neutralize acidic hypoxic cancerous neoplasms |
| 12/16/2004 | US20040253322 Mixtures of clinoptilolite, plant extracts and vitamins, used for attenuation of neuropathic pain associated with diabetes or prevent deposition of immunoglobulin on axons |
| 12/16/2004 | US20040253320 A mixture of vitamins, minerals, simethicone for patients suffering inflammatory bowel disease; calcium carbonate, calcium sulphate; non-allergenic, improve absorption and side effect reduction |
| 12/16/2004 | US20040253319 Pharmaceutical compositions and method for alleviating side-effects of estrogen replacement therapy |
| 12/16/2004 | US20040253318 Preventing, alleviating symptoms of a skin condition with a complexes, such as lauryliminodipropionic acid tocopheryl phosphate; penetrating and absorption into skin; inflammation, erythema, wound, burn, dermatitis, gingivitis, sunburn, heat burn, psoriasis; cosmetics |
| 12/16/2004 | US20040253316 Production scale method of forming microparticles |
| 12/16/2004 | US20040253311 Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines |
| 12/16/2004 | US20040253309 Tablets are disintegrated in the mouth cavity; comprising enterosoluble substance polymer or fatty acid, water insoluble substance polymer or wax; controlling the drug release, preventing the side effect of sudden rise in the plasma concentration |
| 12/16/2004 | US20040253308 Surface-treated modafinil particles |
| 12/16/2004 | US20040253307 Sugar-free oral transmucosal solid dosage forms and uses thereof |
| 12/16/2004 | US20040253306 Sustained release formulations for nifedipine dextromethorphan, and danazol |
| 12/16/2004 | US20040253305 Pharmaceutical compositions of atorvastatin |
| 12/16/2004 | US20040253302 Compositions and methods for treating lymphoma |
| 12/16/2004 | US20040253301 Transdermal therapeutic system comprising a reservoir type pressure sensitive adhesive layer and a back layer with uni-directional resilience |
| 12/16/2004 | US20040253300 Medication and method for remediating existing scars through transdermal, topical delivery of calcium channel blockers |
| 12/16/2004 | US20040253299 Controlled release drug delivery device; side effect reduction; Parkinson's disease |
| 12/16/2004 | US20040253296 Food bar for treating musculoskeletal disorders |
| 12/16/2004 | US20040253295 Mixture containing digestion enzyme, vitamins, amino acid |
| 12/16/2004 | US20040253289 Natural plant compound with anti-HIV activity |
| 12/16/2004 | US20040253283 Composition for treating keratinous materials, comprising a hydroxycarboxylic acid and a protective and/or conditioning agent |
| 12/16/2004 | US20040253282 Cosmetic and dermatological preparations containing carnitine for treating and actively preventing dry skin and other negative alterations in the physiological homeostasis of healthy skin |
| 12/16/2004 | US20040253277 Anaesthetic formulations of propofol |
| 12/16/2004 | US20040253276 Oil-in-water emulsion of a 1-carboxylate-6-arylsulfamoyl cyclohexene and synthetic and naturally occurring phospholipids; nitric oxide or cytokine prodution inhibitors; cardiovascular disorders, autoimmune dieseases, septic shock; improved stability during autoclave sterilization |
| 12/16/2004 | US20040253275 Pharmaceutical and cosmetic carrier or composition for topical application |
| 12/16/2004 | US20040253244 Methods for treating pain by administering a nerve growth factor antagonist and an NSAID and compositions containing the same |
| 12/16/2004 | US20040253233 genetic engineered chimeric and humanized antibodies obtained from murine monoclonal antibody P3 (MAb P3) and its antiidiotypic antibodies, used as antitumor agents |
| 12/16/2004 | US20040253231 monoclonal or polyclonal antibodies having specific reactivity with adenosine triphosphate binding domains, caspase recruitment domains and triosephosphate isomerase domain peptides, used for modulation of apoptosis |
| 12/16/2004 | US20040253229 administering a mixture of carriers and drugs that modulate signal transduction mediated by activation inducible lymphocyte immunomodulatory molecule (AILIM); immunosuppressants |
| 12/16/2004 | US20040253227 mixture of enzymes, amino acids, seaweed and derivatives, flavors, vitamins, fibers and fluids, used for promoting metabolism |
| 12/16/2004 | US20040253223 Treatment of aging disorders in humans |
| 12/16/2004 | US20040253220 amino acid sequences of human oxidoreductase enzymes, used for activating expression of elastin; cosmetics |
| 12/16/2004 | US20040253219 injection of curing agents selected from genipin, proanthocyanidin, ribose, threose, and lysyl oxidase into the convex side of intervertebral discs, to reduce bending hysteresis and increasing bending stiffness |
| 12/16/2004 | US20040253216 Activated checkpoint therapy and methods of use thereof |
| 12/16/2004 | US20040253214 fusing cells; nucleic acid vector comprises a nucleotide sequence encoding a measles virus F glycoprotein and a nucleotide sequence encoding a chimeric measles virus H glycoprotein; nucleotide sequence encoding a syncytium-inducing polypeptide expressible on a eukaryotic cell surface |
| 12/16/2004 | US20040253206 etoposide; hydrophobic drug attached to amphiphilic ethylene glycol oligomer or polymer via hydrolyzable bond; improves ability to penetrate blood-brain barrier; bond hydrolyzes in vivo, freeing the fully bioactive drug; improves solubility of the drug in the bloodstream; drug delivery to CNS |
| 12/16/2004 | US20040253201 Polyvalent metal-substituted starch products |
| 12/16/2004 | US20040253194 Pyrithione biocides enhanced by zinc metal ions and organic amines |
| 12/16/2004 | US20040253193 metronidazole and nystatin with a carrier; mouthwash |
| 12/16/2004 | US20040253191 Breath Freshening and Oral Cleansing Product |
| 12/16/2004 | US20040253190 Breath Freshening and Oral Cleansing Product Using Citral |
| 12/16/2004 | US20040253177 Fatty acid derivatives; tissue-targeted therapy; tomography; cardiovascular disorders; liver disorders; kits |
| 12/16/2004 | US20040253139 Applying an alkyl lactate as disinfectant to a kitchen or bathroom surface; microbiocide |
| 12/16/2004 | DE29724846U1 Preparation of 6-O-methyl erythromycin A crystal Form II - from erythromycin, treating with solvent, and isolating, useful as an antibiotic |
| 12/16/2004 | DE10324496A1 Targetorientierte Chemotherapie von Tumoren der Sexualorgane Target-oriented chemotherapy of tumors of the sexual organs |
| 12/16/2004 | DE10324282A1 Kombination von Acetylsalicylsäure und Alpha-Glucosidase-Inhibitoren Combination of acetylsalicylic acid and alpha-glucosidase inhibitors |
| 12/16/2004 | DE10323966A1 Neue langwirksame Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen New long-acting drug combinations for the treatment of respiratory disorders |
| 12/16/2004 | DE10323837A1 Formulation useful in the treatment of neurogenic and idiopathic bladder hyperactivity comprises phenoxyacetic acid derivative |
| 12/16/2004 | DE10323759A1 Heilmittel zur inneren Anwendung, insbesondere gegen Krebserkrankungen Remedies for internal use, especially against cancer |
| 12/16/2004 | DE10323758A1 Heilmittel zur inneren Anwendung, insbesondere gegen Krebserkrankungen Remedies for internal use, especially against cancer |
| 12/16/2004 | DE10323345A1 Neue Pyridopyrazine und deren Verwendung als Kinase-Inhibitoren New Pyridopyrazine and their use as kinase inhibitors |
| 12/16/2004 | DE10323279A1 Gebrauchsfertige Gemcitabin-Lösungen Ready gemcitabine solutions |
| 12/16/2004 | DE10323278A1 Gebrauchsfertige Gemcitabin-Lösungskonzentrate Ready gemcitabine solution concentrates |
| 12/16/2004 | CA2561452A1 Neuroprotective benzoate and benzamide compounds |
| 12/16/2004 | CA2550929A1 Antiseptic compositions, methods and systems |
| 12/16/2004 | CA2531561A1 11-12 bicyclic erythromycin derivatives |
| 12/16/2004 | CA2528975A1 Therapeutic combinations comprising pde inhibitors and vasopressin receptor antagonists for the treatment of dysmenorrhoea |
| 12/16/2004 | CA2528925A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 12/16/2004 | CA2528924A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 12/16/2004 | CA2528897A1 Combined pharmaceutical preparations for the treatment of cancer, containing glutaminase and antineoplastic anthracyclines or platinum compounds |
| 12/16/2004 | CA2528756A1 Tetrahydroisoquinolines as antagonists of the 5ht1b receptor |
| 12/16/2004 | CA2528522A1 Antimicrobial flush solutions |
| 12/16/2004 | CA2528497A1 Tricyclic compound |
| 12/16/2004 | CA2528233A1 Aroylsemicarbazide derivatives against thromboembolic diseases |
| 12/16/2004 | CA2528179A1 Piperidinyl prostaglandin e analogs |
| 12/16/2004 | CA2528164A1 Solid preparation |
| 12/16/2004 | CA2528156A1 Staurosporine derivatives for hypereosinophilic syndrome |
| 12/16/2004 | CA2528136A1 Transfection agents |
| 12/16/2004 | CA2528093A1 Aryl-heteroaromatic products, compositions containing same and use thereof |
| 12/16/2004 | CA2528065A1 Beta-lactamase inhibitor prodrug |
| 12/16/2004 | CA2528044A1 Nitrogen-containing heteroaryl derivatives for the treatment of hcv-infection |
| 12/16/2004 | CA2528032A1 Methods and compounds for the treatment of vascular stenosis |
| 12/16/2004 | CA2528006A1 8-azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents |
| 12/16/2004 | CA2527994A1 Process for producing microparticles |
| 12/16/2004 | CA2527989A1 Glycyrrhizin or derivatives thereof for treating or preventing severe acute respiratory syndrome (sars) |
| 12/16/2004 | CA2527967A1 Biologically active oils |
| 12/16/2004 | CA2527940A1 Nutritional supplements and therapeutic compositions comprising (r)-3-hydroxybutyrate derivatives |
| 12/16/2004 | CA2527934A1 Tetrazol benzofurancarboxamides with p13k activity as therapeutic agents |
| 12/16/2004 | CA2527814A1 Isoindolin-1-one compounds as kinase inhibitors |
| 12/16/2004 | CA2527799A1 Methods for identifying modulators of kinesin activity |
| 12/16/2004 | CA2527793A1 3-arylsulfanyl and 3-heteroarylsulfanyl substituted benzo[b]thiophenes as therapeutic agents |
| 12/16/2004 | CA2527788A1 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamine derivatives as beta 2-adrenoceptors agonists |
| 12/16/2004 | CA2527779A1 3-substituted indoles and derivatives thereof as therapeutic agents |
| 12/16/2004 | CA2527769A1 7- (1, 3-thiazol-2-yl)thio!-coumarin derivatives and their use as leukotriene biosynthesis inhibitors |
| 12/16/2004 | CA2527711A1 Inhibition of sars coronavirus infection with clinically approved antiviral drugs |
| 12/16/2004 | CA2527702A1 Processes for making caralluma extracts and uses |
| 12/16/2004 | CA2527693A1 Polymorphic forms of naltrexone |
| 12/16/2004 | CA2527658A1 Methods and compositions for interferon therapy |
| 12/16/2004 | CA2527576A1 3-aryloxy and 3-heteroaryloxy substituted benzo(b) thiophenes as therapeutic agents with pi3k activity |
| 12/16/2004 | CA2527573A1 Cycloalkyl and heterocycloalkyl substituted benzothiophenes as therapeutic agents |
| 12/16/2004 | CA2527341A1 Cycloalkylsulfanyl substituted benzo[b]thiophenes as therapeutic agents |
| 12/16/2004 | CA2527334A1 2-amino-pyridine derivatives as beta-2 adrenoreceptor agonists |